Literature DB >> 34196224

Micro- and nanotechnological delivery platforms for treatment of dysbiosis-related inflammatory bowel disease.

Dingpei Long1, Didier Merlin1,2.   

Abstract

Entities:  

Keywords:  fecal microbiota transplantation; gut microbiota; inflammatory bowel disease; inorganic nanoparticles; intestinal dysbiosis; lipid nanoparticles; microbiome metabolites; nanotechnology

Mesh：

Year:  2021        PMID： 34196224      PMCID： PMC8336662          DOI： 10.2217/nnm-2021-0167

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   6.096


× No keyword cloud information.
  29 in total

Review 1.  Cancer in inflammatory bowel disease: lessons from animal models.

Authors:  Daniel A Sussman; Rebeca Santaolalla; Sebastian Strobel; Rishu Dheer; Maria T Abreu
Journal:  Curr Opin Gastroenterol       Date:  2012-07       Impact factor: 3.287

2.  World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010.

Authors:  Charles N Bernstein; Michael Fried; J H Krabshuis; Henry Cohen; R Eliakim; Suleiman Fedail; Richard Gearry; K L Goh; Saheed Hamid; Aamir Ghafor Khan; A W LeMair; Qin Ouyang; J F Rey; Ajit Sood; Flavio Steinwurz; Ole O Thomsen; Alan Thomson; Gillian Watermeyer
Journal:  Inflamm Bowel Dis       Date:  2010-01       Impact factor: 5.325

Review 3.  Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

Authors:  Khurram J Khan; Thomas A Ullman; Alexander C Ford; Maria T Abreu; Amir Abadir; A Abadir; John K Marshall; Nicholas J Talley; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2011-03-15       Impact factor: 10.864

4.  Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders.

Authors:  Elaine Y Hsiao; Sara W McBride; Sophia Hsien; Gil Sharon; Embriette R Hyde; Tyler McCue; Julian A Codelli; Janet Chow; Sarah E Reisman; Joseph F Petrosino; Paul H Patterson; Sarkis K Mazmanian
Journal:  Cell       Date:  2013-12-05       Impact factor: 41.582

Review 5.  Adverse effects of biologics used for treating IBD.

Authors:  Andreas Stallmach; Stefan Hagel; Tony Bruns
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-04       Impact factor: 3.043

6.  A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota.

Authors:  Chenwen Li; Yang Zhao; Juan Cheng; Jiawei Guo; Qixiong Zhang; Xiangjun Zhang; Jiong Ren; Fengchao Wang; Jun Huang; Houyuan Hu; Ruibing Wang; Jianxiang Zhang
Journal:  Adv Sci (Weinh)       Date:  2019-08-01       Impact factor: 16.806

7.  Human Colon Mucosal Biofilms and Murine Host Communicate via Altered mRNA and microRNA Expression during Cancer.

Authors:  Sarah Tomkovich; Raad Z Gharaibeh; Cynthia L Sears; Christian Jobin; Christine M Dejea; Jillian L Pope; Jinmai Jiang; Kathryn Winglee; Josee Gauthier; Rachel C Newsome; Ye Yang; Anthony A Fodor; Thomas D Schmittgen
Journal:  mSystems       Date:  2020-01-14       Impact factor: 6.496

8.  Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis.

Authors:  Yonghyun Lee; Kohei Sugihara; Merritt G Gillilland; Sangyong Jon; Nobuhiko Kamada; James J Moon
Journal:  Nat Mater       Date:  2019-08-19       Impact factor: 47.656

Review 9.  Nanoparticles in the Food Industry and Their Impact on Human Gut Microbiome and Diseases.

Authors:  Merry Ghebretatios; Sabrina Schaly; Satya Prakash
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

10.  Microencapsulation in Alginate and Chitosan Microgels to Enhance Viability of Bifidobacterium longum for Oral Delivery.

Authors:  Timothy W Yeung; Elif F Üçok; Kendra A Tiani; David J McClements; David A Sela
Journal:  Front Microbiol       Date:  2016-04-19       Impact factor: 5.640
View more
  1 in total

Review 1.  Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives.

Authors:  Mengfan Li; Lijiao Yang; Chenlu Mu; Yue Sun; Yu Gu; Danfeng Chen; Tianyu Liu; Hailong Cao
Journal:  Comput Struct Biotechnol J       Date:  2022-04-04       Impact factor: 6.155
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.